DE69131907D1 - Thienodiazepinverbindungen und ihre verwendung - Google Patents

Thienodiazepinverbindungen und ihre verwendung

Info

Publication number
DE69131907D1
DE69131907D1 DE69131907T DE69131907T DE69131907D1 DE 69131907 D1 DE69131907 D1 DE 69131907D1 DE 69131907 T DE69131907 T DE 69131907T DE 69131907 T DE69131907 T DE 69131907T DE 69131907 D1 DE69131907 D1 DE 69131907D1
Authority
DE
Germany
Prior art keywords
antidemential
cholecystokinin
useful
inhibitory action
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69131907T
Other languages
English (en)
Other versions
DE69131907T2 (de
Inventor
Yoichi Naka
Keiichiro Haga
Masahiro Hosoya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of DE69131907D1 publication Critical patent/DE69131907D1/de
Application granted granted Critical
Publication of DE69131907T2 publication Critical patent/DE69131907T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69131907T 1991-09-30 1991-09-30 Thienodiazepinverbindungen und ihre verwendung Expired - Fee Related DE69131907T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002097285A CA2097285C (en) 1991-09-30 1991-09-30 Thienodiazepine compounds and their use
PCT/JP1991/001315 WO1993007152A1 (fr) 1991-09-30 1991-09-30 Compose a base de thienodiazepine et son utilisation

Publications (2)

Publication Number Publication Date
DE69131907D1 true DE69131907D1 (de) 2000-02-17
DE69131907T2 DE69131907T2 (de) 2000-06-15

Family

ID=25676237

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131907T Expired - Fee Related DE69131907T2 (de) 1991-09-30 1991-09-30 Thienodiazepinverbindungen und ihre verwendung

Country Status (8)

Country Link
US (1) US5439905A (de)
EP (1) EP0559891B1 (de)
KR (1) KR970002640B1 (de)
AT (1) ATE188702T1 (de)
CA (1) CA2097285C (de)
DE (1) DE69131907T2 (de)
ES (1) ES2140396T3 (de)
WO (1) WO1993007152A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022872A1 (en) * 1993-03-30 1994-10-13 Yoshitomi Pharmaceutical Industries, Ltd. Cell adhesion inhibitor and thienotriazolodiazepine compound
US5426185A (en) * 1993-11-22 1995-06-20 Merck & Co., Inc. Antiarrhythmic benzodiazepines
WO1995032963A1 (fr) * 1994-06-01 1995-12-07 Yoshitomi Pharmaceutical Industries, Ltd. Compose de thienylazole et compose de thienotriazolodiazepine
EP0776208B1 (de) * 1994-08-18 1999-11-10 Merck & Co. Inc. 2,3-dihydro-1-(2,2,2-trifluorethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepine
US5631251A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. 5-cyclopropyl-1,4 benzodiazepine-2-ones
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
US5700797A (en) * 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
JPH11506760A (ja) * 1995-06-07 1999-06-15 メルク エンド カンパニー インコーポレーテッド 新規なｎ−（２，４−ジオキソ−２，３，４，５−テトラヒドロ−１ｈ−１，５−ベンゾジアゼピン−３イル）−３−アミド
US5726171A (en) * 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
CA2257948A1 (en) * 1996-06-28 1998-01-08 Merck & Co., Inc. Antiarrhythmic combinations of selective iks antagonists with beta-adenergic blocking agents
US5776930A (en) * 1996-06-28 1998-07-07 Merck & Company, Inc. Pharmaceutical preparation
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
EP2705039B1 (de) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomainhemmer und ihre verwendung
EP2721031B1 (de) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomainhemmer und ihre verwendungen
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
CA2952830C (en) 2014-06-20 2022-11-01 Constellation Pharmaceuticals, Inc. Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
KR101675984B1 (ko) 2015-02-23 2016-11-14 한양대학교 에리카산학협력단 티에노디아제핀 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348523A4 (en) * 1987-12-22 1991-10-09 Yoshitomi Pharmaceutical Industries, Ltd. Thienodiazepine compounds and their medicinal use
JP2953045B2 (ja) * 1989-12-01 1999-09-27 吉富製薬株式会社 チエノジアゼピン化合物
IL96613A0 (en) * 1989-12-18 1991-09-16 Merck & Co Inc Pharmaceutical compositions containing benzodiazepine analogs

Also Published As

Publication number Publication date
WO1993007152A1 (fr) 1993-04-15
CA2097285C (en) 2000-03-14
US5439905A (en) 1995-08-08
KR970002640B1 (ko) 1997-03-07
ES2140396T3 (es) 2000-03-01
ATE188702T1 (de) 2000-01-15
CA2097285A1 (en) 1993-03-31
EP0559891A1 (de) 1993-09-15
EP0559891A4 (de) 1994-03-16
EP0559891B1 (de) 2000-01-12
DE69131907T2 (de) 2000-06-15

Similar Documents

Publication Publication Date Title
ATE188702T1 (de) Thienodiazepinverbindungen und ihre verwendung
EP0348523A4 (en) Thienodiazepine compounds and their medicinal use
ATE334975T1 (de) Sulfonamidderivate, ihre herstellung und verwendung
ES2119124T3 (es) Bencimidazoles utiles para el tratamiento de trastornos del sistema nervioso.
NO985711L (no) Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
NO304793B1 (no) nor-gallesyrederivater, og anvendelse av dem for fremstilling av legemiddel
ES8303293A1 (es) "procedimiento de preparar derivados carboxamidicos".
FI942075A0 (fi) Sappihappojohdannaisten tetratsolijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
NZ514487A (en) Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
DE68919378T2 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
DK521685D0 (da) Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning
DE3587112D1 (de) 2-quaternaer-pyridinalkylthio- oder -pyridinalkenylthiosubstituierte carbapeneme, diese enthaltende zusammensetzungen und ihre zusammenstellungen mit dhp-inhibitoren.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
WO2001022951A3 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
ATE88634T1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
DE3872425T2 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
ATE306483T1 (de) Alkoxy-substituierte benzimidazolverbindungen , diese enthaltende arzneimittel und ihre verwendung
DE69411852D1 (de) Indolderivate, ihre Salze und sie enthaltende Arzneimittel zur Behandlung von Herzkrankheiten
ES8800200A1 (es) Un proceso para produccion de un derivado del indol.
DE3887612T2 (de) Salicylate, ihre Salze, diese enthaltende pharmazeutische Kompositionen und ihr Herstellungsverfahren.
NO933199D0 (no) Heteroarenylpiperaziner, fremgangsm}te for deres fremstilling og anvendelse derav som legemidler
DK0686641T3 (da) 2'-Deoxy-5-fluoruridinderivat, farmaceutisk acceptabelt salt deraf, fremgangsmåde til fremstilling deraf, og antitumorlægem
WO2000050017A3 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee